DUBLIN--(BUSINESS WIRE)--The "2018 US Molecular Diagnostic Analyzers and Reagents: Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers" report has been added to ResearchAndMarkets.com's offering.
This 1,157-page report contains 65 tables, and presents a comprehensive analysis of the US molecular diagnostics market, including:
- Major issues pertaining to the US molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
- An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
-
Five-year test volume and reagent sales forecasts for the following
categories:
- Infectious Diseases
- Forensic Testing
- Cancer
- Paternity Testing/HLA Typing
- Genetic Diseases
- Others
- Review of testing methodologies an instrumentation technologies.
- Feature comparison of automated and semiautomated analyzers.
- Sales and market shares of leading suppliers.
- Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
- Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in RD, collaborative arrangements and business strategies.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
- Business planning issues and concerns.
For more information about this report visit https://www.researchandmarkets.com/research/gndfx5/2018_us_molecular?w=4
